Philip I. Murray

ZD1839, a Selective Oral Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Trial

Malcolm Ranson, Lisa A. Hammond, D. K. Ferry et al. · Journal of Clinical Oncology · 2002 · 763 citations

Medicine, Oncology, Pharmacology +14

Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis

Andrew D. Dick, James T. Rosenbaum, Hassan Al-Dhibi et al. · Ophthalmology · 2018 · 266 citations · Full text

Medicine, Immunology, Ophthalmology +17

International Uveitis Study Group (IUSG) Clinical Classification of Uveitis

Jean Deschênes, Philip I. Murray, Narsing A. Rao et al. · Ocular Immunology and Inflammation · 2008 · 254 citations

Health Professions, Ophthalmology, Clinical Classification Systems +8

Multiplex Bead Immunoassay Analysis of Aqueous Humor Reveals Distinct Cytokine Profiles In Uveitis

John Curnow, Francesco Falciani, Omar M. Durrani et al. · Investigative Ophthalmology & Visual Science · 2005 · 219 citations

Medicine, Immunology, Pathology +17

Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer

Syed A. Hussain, Raji Ganesan, Gary Reynolds et al. · British Journal of Cancer · 2007 · 193 citations · Full text

Medicine, Cancer Biology, Oncology +17